Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Navigating Early Cell Therapy Development: The Journey to First-in-Human Studies, Upcoming Webinar Hosted by Xtalks | ||
| By: PR Newswire Association LLC. - 15 Feb 2024 | Back to overview list |
|
|
In this webinar, gain insights into overarching regulatory strategies that maximize the effectiveness of interactions with the FDA and other regulatory bodies. Attendees will learn about manufacturing processes to meet the demands of cell therapy clinical trials, including scalability, reproducibility and the establishment of robust quality control measures. The featured speakers will share considerations for designing nonclinical studies that will lay the groundwork for first-in-human and subsequent clinical trials, drawing on real-world case studies. TORONTO, Feb. 15, 2024 /PRNewswire-PRWeb/ -- For cell therapies, the roadmap to first-in-human studies is marked by critical scientific and regulatory milestones that require careful planning, expertise and collaboration from various stakeholders. From rigorous nonclinical studies to cell manufacturing processes to overcoming regulatory complexities, each milestone represents a significant step forward in bringing these transformative treatments to patients in need. Register for this webinar where representatives from Premier Research and Biocentriq will host a panel discussion delving into the intricacies of early cell therapy development that shape the path toward clinical trials. Join Gregory Meyer, Vice President, Regulatory Affairs, Premier Consulting; Mimi Huang, PhD Toxicologist, Premier Consulting; Alex Klarer, VP of Business Strategy and Innovation, BioCentriq; and Kenneth Ndugga-Kabuye (Moderator), MD, FACMG, Vice President, Cell & Gene Therapy, Premier Research, for the live webinar on Thursday, March 7, 2024, at 11am EST (4pm GMT/UK). For more information, or to register for this event, visit Navigating Early Cell Therapy Development: The Journey to First-in-Human Studies. ABOUT XTALKS Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers. To learn more about Xtalks visit https://xtalks.com Media Contact Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, www.xtalks.com
SOURCE Xtalks 
|
||
|
||
 | Back to overview list | |
View original content to download multimedia: